Like Eastern Europe, Latin America is one of the top emerging markets.  This region shows a great deal of diversity in its approach to pharmaceutical products as a result of differences in economics, resources, access to care, and definition of regulatory requirements by country. Common guidelines from groups like the Pan American Health Organization (PAHO, part of the World Health Organization) and the Mercado Común del Sur (Mercosur, a lead trade organization) are just beginning to be implemented.  Like Eastern Europe, there’s interest in greater harmonization across the region, but there still remains great divergence between individual countries.